Onderneming Applied Genetic Technologies Corporation
Aandelen
AGTC
US03820J1007
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 102
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 01-11-22 |
David Jacobs
CTO | Chief Tech/Sci/R&D Officer | - | 08-06-22 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-12-22 |
Abraham Scaria
CTO | Chief Tech/Sci/R&D Officer | - | 15-11-21 |
Ashwin Datt
BRD | Director/Board Member | - | 01-12-22 |
Chris Hollowood
BRD | Director/Board Member | 50 | 01-12-22 |
Hope D'Oyley-Gay
LAW | General Counsel | - | 11-11-21 |
Gerald Reynolds
TRE | Treasurer | - | 01-03-20 |
Janet Rae
LAW | General Counsel | - | 18-06-21 |
Matthew Feinsod
PRN | Corporate Officer/Principal | - | 01-07-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 01-11-22 |
Chris Hollowood
BRD | Director/Board Member | 50 | 01-12-22 |
Ashwin Datt
BRD | Director/Board Member | - | 01-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 67 686 195 | 67 316 723 ( 99,45 %) | 54 000 ( 0,0798 %) | 99,45 % |
Bedrijfsgegevens
Beacon Therapeutics (USA), Inc.
14193 NW 119th Terrace Suite 10
32615, Alachua
+386 462 2204
http://agtc.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,26% | 103 mld. | |
+1,41% | 95,71 mld. | |
+0,64% | 22,02 mld. | |
-17,84% | 20,9 mld. | |
-9,12% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-17,63% | 15,52 mld. | |
+4,55% | 13,86 mld. | |
+32,11% | 12,04 mld. |